KEMPHARM, INC Loan Agreements
4 Contracts & Agreements
- First Amendment to the Bridge Loan Agreement by and between the Registrant and Acer Therapeutics Inc (Filed With SEC on April 1, 2024)
- Loan Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto (Filed With SEC on August 31, 2023)
- Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc (Filed With SEC on August 31, 2023)
- Revolving Loan Agreement dated May 31, 2022 by and among KemPharm, Inc. and Ameris Bank, as lender (Filed With SEC on June 1, 2022)
